Based on the above evidence, we speculate that in the pre-diabetes stage, before CTRP3 is insufficient to compensate for the severe metabolic disorders of T2DM and/or obesity, the level of CTRP3 may increase through a compensation mechanism. The gene discussed is C1QTNF3; the disease is obesity due to melanocortin 4 receptor deficiency.